Sabai IBC Services
The Sabai Institutional Biosafety Committee (IBC) team leads the way with the most certified biosafety professionals within an organization.
IBC Review
Sabai IBC Services can provide a centralized IBC solution ~ or work with an Institution to create an additional HGT-specific IBC for their facilities.
- Flexible and comprehensive support for IBC setup, NIH registration and administration
- Personalized education on IBCs and NIH requirements for new sites
- Resources and support for an existing IBC through staffing, a second HGT-specific IBC, or other institution specific needs
- Coordination of concurrent reviews to deliver efficient, time-saving IBC and Institutional Review Board (IRB) reviews for all participating research sites throughout our services
- Global support for IBC services as research with the NIH Guidelines goes beyond US borders
Why Do I Need An IBC?
Review of a clinical trial by an Institutional Biosafety Committee is required by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules when:
- 1. The investigational product contains recombinant or synthetic nucleic acids that meet certain criteria under Section III-C of the NIH Guidelines, AND
- 2. This research is conducted at an institution that receives support for recombinant/synthetic nucleic acid research from NIH, or
- 3. This research is sponsored by an institution that receives support for recombinant/synthetic nucleic acid research from NIH, or
- 4. The investigational product was developed with NIH funds if the Institution that developed the IP sponsors or participates in the trial.
5. Still unsure? No problem, contact us today to speak with an expert.
Sabai IBC Services has developed several frequently requested guidance documents to assist our clinicians and researchers. The following items are available for download below.
FAQ
Guidance
